The device as well as the production are certified according to the EC guidelines 93/42/EEC Annex II as well as EN ISO 13485.
papimi is a certified and approved medical device of class IIa.
The American patent was granted on September 17, 1996 (US 5,556,418). The first European patent (EP 0648.140.B1) was granted on January 31, 2001 and the second (EP 04.743.704.1) in August 2003.
Our premium service ensures that your device always performs flawlessly. Our staff will also inform you about our many warranty options.
The device as well as the production are certified according to the EC guidelines 93/42/EEC Annex II as well as EN ISO 13485.
papimi is a certified and approved medical device of class IIa.
The American patent was granted on September 17, 1996 (US 5,556,418). The first European patent (EP 0648.140.B1) was granted on January 31, 2001 and the second (EP 04.743.704.1) in August 2003.
Our premium service ensures that your device always performs flawlessly. Our staff will also inform you about our many warranty options.
Prof Dr med Thomas Rau
BioMed Center Sonnenberg AG
Prof Dr med Thomas Rau
BioMed Center Sonnenberg AG
Prof. Heinrich Bergmüller
Bergmüller Zentrum
Prim Dr med Gerhard Fürst
Medical Director Gesundheitspark Murau, Austria
Klaus Meierstein
Head of physical therapy at 1. FC Köln
The papimiCON'23, our conference on Effective Medicine, was a tremendous success, warmly received by our diverse attendees from around the world. Explore and download the images of the event here. ...
We are glad to announce our participation in the 2nd International Ozone Congress hosted by HAB at the Baltic Sea Coast. Learn more about the event and our participation here...